19-2430922-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_032737.4(LMNB2):āc.1852T>Cā(p.Tyr618His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000604 in 1,606,742 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032737.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNB2 | ENST00000325327.4 | c.1852T>C | p.Tyr618His | missense_variant | 12/12 | 1 | NM_032737.4 | ENSP00000327054.3 | ||
LMNB2 | ENST00000475819.1 | n.48-614T>C | intron_variant | 5 | ||||||
LMNB2 | ENST00000532465.1 | n.413+626T>C | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000917 AC: 23AN: 250748Hom.: 1 AF XY: 0.000140 AC XY: 19AN XY: 135710
GnomAD4 exome AF: 0.0000619 AC: 90AN: 1454392Hom.: 1 Cov.: 28 AF XY: 0.0000953 AC XY: 69AN XY: 724042
GnomAD4 genome AF: 0.0000459 AC: 7AN: 152350Hom.: 0 Cov.: 33 AF XY: 0.0000805 AC XY: 6AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | The c.1792T>C (p.Y598H) alteration is located in exon 12 (coding exon 12) of the LMNB2 gene. This alteration results from a T to C substitution at nucleotide position 1792, causing the tyrosine (Y) at amino acid position 598 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Lipodystrophy, partial, acquired, susceptibility to;C4225289:Progressive myoclonic epilepsy type 9 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 02, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at